(Q34766063)

4 August 2017

1 reference

title

Interleukin-1--a major pleiotropic cytokine in tumor-host interactions (English)

1 reference

4 August 2017

0 references

1 reference

Ron N Apte

1

1 reference

4 August 2017

Elena Voronov

series ordinal

2

1 reference

4 August 2017

publication date

1 August 2002

1 reference

Seminars in Cancer Biology

4 August 2017

published in

1 reference

4 August 2017

volume

12

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

277-290

1 reference

The interleukin 1 receptor: ligand interactions and signal transduction

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Regulation of inhibitory pathways of the interleukin-1 system

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

1 reference

7 January 2021

Interleukin 1 and T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Costimulatory regulation of T cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Role of interleukin 1 in the activation of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Modulation of interleukin-1 alpha mRNA expression in mouse epidermis by tumor promoters and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin-1 Beta Gene Deregulation Associated With Chromosomal Rearrangement: A Candidate Initiating Event for Murine Radiation-Myeloid Leukemogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Tumors are unique organs defined by abnormal signaling and context

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Proteases in invasion: matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Cytokines as communication signals between leukocytes and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

The role of CXC chemokines as regulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin 1-dependent and -independent mouse melanoma metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activities in normal and LPS-injected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Modulation of Acute Myeloblastic Leukemia (AML) Cell Proliferation and Blast Colony Formation by Antisense Oligomer for IL-1 Beta Converting Enzyme (ICE) and IL-1 Receptor Antagonist (IL-1ra)

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Modulatory in vitro effects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1beta converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Autocrine and paracrine regulation by cytokines and growth factors in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Neuroendocrine and immune mediators in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Expression of interleukin-1beta in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Autoregulation of the interleukin-1 system and cytokine-cytokine interactions in primary human astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Enhancing Effect of Interleukin 1α Administration on Antitumor Effector T-Cell Development

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Modulation of specific active immunization against murine melanoma using recombinant cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Systemic IL-1 and adjuvant treatment of an experimental tumor. I. Immune status following tumor rechallenge

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Systemic IL-1 and adjuvant treatment of an experimental tumor. II. Immune status during primary tumor challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin-1 produced by tumorigenic fibroblasts influences tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin-1 production by transformed fibroblasts. II. Influence on antigen presentation and T-cell-mediated anti-tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using 'cracked' adenoproducer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900014-7

7 January 2021

10.1016/S1044-579X(02)00014-7

Identifiers

DOI

1 reference

4 August 2017

1 reference